Natriuretic peptides are also known to antagonise cardiac hypertrophy independently of blood pressure [31, 32], and in humans, certain ANP- and BNP-receptor polymorphisms have been associated with LV mass in essential hypertension [33]. Here, NPPA is linked to cardiac hypertrophy.